Tag - CellCept

Feature

Aurinia to begin lupus nephritis trial at end of April

By Len Zehr Fresh from a US$52-million private placement, Aurinia Pharmaceuticals (TSX-V:AUP) hopes to treat its first lupus patient at the end of April in a Phase 2b clinical trial with its voclosporin...

April 15, 2014

Feature

Aurinia readies Phase 2b trial in lupus nephritis

By Len Zehr Aurinia Pharmaceuticals (TSX-V:AUP) is preparing to begin a Phase 2b clinical trial in the first quarter of 2014 with its voclosporin immunosuppressant in combination with CellCept, the standard of care for...

November 19, 2013

Tag - CellCept

Aurinia to begin lupus nephritis trial at end of April

Aurinia readies Phase 2b trial in lupus nephritis

General

More